- Home
- PLSE vs VMEO Comparison
PLSE vs VMEO Comparison
Compare PLSE & VMEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- VMEO
- Stock Information
- Founded
- PLSE 2014
- VMEO 2004
- Country
- PLSE United States
- VMEO United States
- Employees
- PLSE N/A
- VMEO 1070
- Industry
- PLSE Medical/Dental Instruments
- VMEO Computer Software: Prepackaged Software
- Sector
- PLSE Health Care
- VMEO Technology
- Exchange
- PLSE Nasdaq
- VMEO Nasdaq
- Market Cap
- PLSE 1.1B
- VMEO 1.0B
- IPO Year
- PLSE 2016
- VMEO N/A
- Fundamental
- Price
- PLSE $17.97
- VMEO $6.26
- Analyst Decision
- PLSE
- VMEO Buy
- Analyst Count
- PLSE 0
- VMEO 3
- Target Price
- PLSE N/A
- VMEO $8.67
- AVG Volume (30 Days)
- PLSE 129.0K
- VMEO 1.4M
- Earning Date
- PLSE 10-30-2024
- VMEO 02-19-2025
- Dividend Yield
- PLSE N/A
- VMEO N/A
- EPS Growth
- PLSE N/A
- VMEO 290.90
- EPS
- PLSE N/A
- VMEO 0.20
- Revenue
- PLSE N/A
- VMEO $419,394,000.00
- Revenue This Year
- PLSE N/A
- VMEO $1.32
- Revenue Next Year
- PLSE N/A
- VMEO $2.07
- P/E Ratio
- PLSE N/A
- VMEO $31.62
- Revenue Growth
- PLSE N/A
- VMEO 0.52
- 52 Week Low
- PLSE $6.60
- VMEO $3.43
- 52 Week High
- PLSE $22.69
- VMEO $7.90
- Technical
- Relative Strength Index (RSI)
- PLSE 49.90
- VMEO 43.27
- Support Level
- PLSE $17.18
- VMEO $5.91
- Resistance Level
- PLSE $19.90
- VMEO $6.44
- Average True Range (ATR)
- PLSE 1.04
- VMEO 0.23
- MACD
- PLSE 0.04
- VMEO -0.03
- Stochastic Oscillator
- PLSE 35.58
- VMEO 27.88
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. Its comprehensive and cloud-based tools empower its users to create, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.